Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906433 · ClinicalTrials.gov registry record · Phase 1
Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis
A Phase 1 study of Knee Osteoarthritis, sponsored by Foundation for Orthopaedic Research and Education.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT05906433 is a Phase 1 study of Knee Osteoarthritis that is actively recruiting participants, run by Foundation for Orthopaedic Research and Education. The registered enrollment target is 75 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05906433, a Phase 1 study of Knee Osteoarthritis, is actively recruiting participants, sponsored by Foundation for Orthopaedic Research and Education.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate pain relief from corticosteroid injection with and without anesthetic as well as with variable volume of anesthetic. Pain relief will be measured using the VAS pain score at the time of the injection as well as several time points following the injection to capture pain relief longevity. The investigators intend to evaluate how well the patients tolerate corticosteroid mixtures without anesthetic as well as with different volumes of anesthetic. Primary measure will be the time from procedure when postoperative status is considered success (as measured by global perceived improvement score).
Conditions Studied
Interventions
- DRUG Kenalog with bupivacaine Injection
Study Locations (1)
Florida
- Florida Orthopaedic Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05906433
The ClinicalTrials.gov registry entry for NCT05906433 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (75% lower). The listed sponsor is Foundation for Orthopaedic Research and Education, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Kenalog with bupivacaine Injection is the first listed.
NCT05906433 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05906433 about?
NCT05906433 is a clinical study titled "Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis". To evaluate pain relief from corticosteroid injection with and without anesthetic as well as with variable volume of anesthetic. Pain relief will be measured using the VAS pain score at the time of the injection as well as several time points following the injection to capture pain relief longevity....
What is the current status of trial NCT05906433?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2023-06-01. Estimated completion is 2025-12-01.
What conditions does trial NCT05906433 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT05906433?
The interventions under investigation include: Kenalog with bupivacaine Injection (DRUG).
Who is sponsoring clinical trial NCT05906433?
This trial is sponsored by Foundation for Orthopaedic Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05906433 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis
COMPLETED · Phase 1
-
Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis
COMPLETED · Phase 1
-
Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain
COMPLETED · Phase 1
-
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.